A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma Meeting Abstract


Authors: Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; Dandapani, S.; Drullinsky, P.; Friedberg, J. W.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Hoppe, R. T.; Horwitz, S. M.; Matasar, M. J.; Miller, S. T.; Moskowitz, A. J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Schoder, H.; Straus, D. J.; Yang, J. C.; Younes, A.; Zelenetz, A. D.; Zhang, Z. G.; Yahalom, J.; Moskowitz, C. H.
Abstract Title: A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419401381
PROVIDER: wos
DOI: 10.1182/blood.V130.Suppl_1.734.734
Notes: Meeting Abstract: 734 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Zhigang Zhang
    392 Zhang
  2. Joachim Yahalom
    582 Yahalom
  3. Carol Portlock
    203 Portlock
  4. Craig Moskowitz
    406 Moskowitz
  5. Ariela Noy
    333 Noy
  6. Maria Lia Palomba
    349 Palomba
  7. Steven M Horwitz
    592 Horwitz
  8. Heiko Schoder
    496 Schoder
  9. Andrew D Zelenetz
    736 Zelenetz
  10. Alison Moskowitz
    297 Moskowitz
  11. Paul Hamlin
    256 Hamlin
  12. Matthew J Matasar
    284 Matasar
  13. Philip C Caron
    77 Caron
  14. David J Straus
    351 Straus
  15. Anita Kumar
    148 Kumar
  16. Connie Wing-Ching Lee Batlevi
    173 Batlevi
  17. Joanna C Yang
    41 Yang
  18. Anas Younes
    317 Younes
  19. Shoshana T Miller
    4 Miller